We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Interleukin-33 in asthma: how big of a role does it play?
- Authors
Borish, Larry; Steinke, John W
- Abstract
In complex disorders such as asthma and allergic disease, the goal for developing disease-modifying biotherapeutics is to find a target that is a central instigator of immunologic activity. Interleukin (IL)-33 seems to be such a molecule, as it is one of the earliest-released signaling molecules following epithelial damage and can orchestrate the recruitment and activation of the cells responsible for disease. Unregulated IL-33 activity leads to activation of T-helper type 2 cells, mast cells, dendritic cells, eosinophils, and basophils, ultimately leading to increased expression of cytokines and chemokines that define the disease. As such, IL-33 is an attractive candidate for therapeutic intervention with the goal of ameliorating disease. This review focuses on the role of IL-33 in promoting and maintaining the asthma phenotype.
- Publication
Current allergy and asthma reports, 2011, Vol 11, Issue 1, p7
- ISSN
1534-6315
- Publication type
Journal Article
- DOI
10.1007/s11882-010-0153-8